Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Methotrexate × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 33 Lymphoid 30 Myeloid 9 Plasma cell 3 Dermatologic 3 Sarcoma 2 CNS 2 Breast 2 Other neoplasm 1 Other 1 Head & Neck 1 Classical hematology 1

Conditions

Neurotoxicity Syndromes 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1

Interventions

glucarpidase 1 apraglutide 1 Radiotherapy 1 Quercetin 1 Methotrexate 1 Leucovorin 1 Hydroxychloroquine 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡